<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>combined &#8211; News Journos</title>
	<atom:link href="https://newsjournos.com/tag/combined/feed/" rel="self" type="application/rss+xml" />
	<link>https://newsjournos.com</link>
	<description>Independent News and Headlines</description>
	<lastBuildDate>Mon, 30 Jun 2025 11:44:43 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://newsjournos.com/wp-content/uploads/2025/02/cropped-The_News_Journos_Fav-1-32x32.png</url>
	<title>combined &#8211; News Journos</title>
	<link>https://newsjournos.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Moderna&#8217;s Flu Vaccine Trials Show Promise for Combined Shot Development</title>
		<link>https://newsjournos.com/modernas-flu-vaccine-trials-show-promise-for-combined-shot-development/</link>
					<comments>https://newsjournos.com/modernas-flu-vaccine-trials-show-promise-for-combined-shot-development/?noamp=mobile#respond</comments>
		
		<dc:creator><![CDATA[News Editor]]></dc:creator>
		<pubDate>Mon, 30 Jun 2025 11:44:33 +0000</pubDate>
				<category><![CDATA[Business]]></category>
		<category><![CDATA[Business Ethics]]></category>
		<category><![CDATA[Business Growth]]></category>
		<category><![CDATA[Business News]]></category>
		<category><![CDATA[Business Technology]]></category>
		<category><![CDATA[combined]]></category>
		<category><![CDATA[Consumer Trends]]></category>
		<category><![CDATA[Corporate Finance]]></category>
		<category><![CDATA[Corporate Strategy]]></category>
		<category><![CDATA[Development]]></category>
		<category><![CDATA[Economic Outlook]]></category>
		<category><![CDATA[Entrepreneurship]]></category>
		<category><![CDATA[flu]]></category>
		<category><![CDATA[Global Business]]></category>
		<category><![CDATA[Innovation]]></category>
		<category><![CDATA[Investment Opportunities]]></category>
		<category><![CDATA[Leadership]]></category>
		<category><![CDATA[Management]]></category>
		<category><![CDATA[Market Trends]]></category>
		<category><![CDATA[Mergers & Acquisitions]]></category>
		<category><![CDATA[Modernas]]></category>
		<category><![CDATA[promise]]></category>
		<category><![CDATA[Retail Business]]></category>
		<category><![CDATA[shot]]></category>
		<category><![CDATA[Show]]></category>
		<category><![CDATA[Small Business]]></category>
		<category><![CDATA[Startups]]></category>
		<category><![CDATA[Supply Chain]]></category>
		<category><![CDATA[Trials]]></category>
		<category><![CDATA[Vaccine]]></category>
		<guid isPermaLink="false">https://newsjournos.com/modernas-flu-vaccine-trials-show-promise-for-combined-shot-development/</guid>

					<description><![CDATA[<p>This article is published by News Journos</p>
<p>Moderna Inc. has announced promising results from its experimental mRNA-based flu vaccine, indicating a stronger immune response compared to existing vaccines in late-stage trials. This breakthrough positions the company favorably as it plans to resubmit its application for approval of both its standalone flu shot and a combination vaccine targeting influenza and COVID-19. The FDA&#8217;s [...]</p>
<p>©2025 News Journos. All rights reserved.</p>
]]></description>
										<content:encoded><![CDATA[<p>This article is published by News Journos</p>
<div id="RegularArticle-ArticleBody-5" data-module="ArticleBody" data-test="articleBody-2" data-analytics="RegularArticle-articleBody-5-2">
<p style="text-align:left;">Moderna Inc. has announced promising results from its experimental mRNA-based flu vaccine, indicating a stronger immune response compared to existing vaccines in late-stage trials. This breakthrough positions the company favorably as it plans to resubmit its application for approval of both its standalone flu shot and a combination vaccine targeting influenza and COVID-19. The FDA&#8217;s recent review process reflects a complex regulatory landscape, yet Moderna is optimistic about its potential position as a leader in the market.</p>
<table style="width:100%; text-align:left; border-collapse:collapse;">
<thead>
<tr>
<th style="text-align:left; padding:5px;">
        <strong>Article Subheadings</strong>
      </th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left; padding:5px;">
        <strong>1)</strong> Overview of Moderna&#8217;s Latest Vaccine Development
      </td>
</tr>
<tr>
<td style="text-align:left; padding:5px;">
        <strong>2)</strong> Phase Three Trial Results and Efficacy
      </td>
</tr>
<tr>
<td style="text-align:left; padding:5px;">
        <strong>3)</strong> Regulatory Challenges and Company Response
      </td>
</tr>
<tr>
<td style="text-align:left; padding:5px;">
        <strong>4)</strong> Market Implications and Future Outlook
      </td>
</tr>
<tr>
<td style="text-align:left; padding:5px;">
        <strong>5)</strong> Summary of Health Impact and Community Response
      </td>
</tr>
</tbody>
</table>
<h3 style="text-align:left;">Overview of Moderna&#8217;s Latest Vaccine Development</h3>
<p style="text-align:left;">On March 26, 2024, Moderna Inc. announced that its experimental flu vaccine, based on mRNA technology, has outperformed existing flu shots during late-stage clinical trials. This marks a significant step for the company as it also aims to provide a combination vaccine that addresses both influenza and COVID-19. With the backdrop of a challenging flu season that resulted in heightened hospitalizations, this new development highlights the urgent need for more effective vaccines, especially among older populations. Moderna’s commitment to addressing this need underscores its potential to reshape the landscape of vaccine efficacy.</p>
<h3 style="text-align:left;">Phase Three Trial Results and Efficacy</h3>
<p style="text-align:left;">The recently concluded phase three trial involved over 40,000 adults aged 50 and above. The participants were randomly assigned to receive a single dose of Moderna’s mRNA-1010 flu vaccine or a standard competitor vaccine. The findings revealed that Moderna&#8217;s vaccine exhibited an effectiveness rate that was 26.6% higher than the standard flu vaccine across the entire study population. Notably, the efficacy extended across major influenza strains, including A/H1N1, A/H3N2, and B/Victoria. Specifically, among adults aged 65 and older, the vaccine demonstrated a 27.4% higher effectiveness compared to the conventional vaccine.</p>
<h3 style="text-align:left;">Regulatory Challenges and Company Response</h3>
<p style="text-align:left;">In May, Moderna proactively withdrew its application seeking approval for its combination vaccine, which targets both COVID-19 and influenza. The decision followed consultations with the Food and Drug Administration (FDA), particularly in light of recent changes to vaccine policies under the administration of Health and Human Services Secretary. These shifts influence regulatory scrutiny over vaccine efficacy and safety protocols. Moderna plans to resubmit its combination vaccine application, leveraging the recent trial data from its standalone flu vaccine. The company is currently in close discussions with the FDA to clarify regulatory requirements and expedite approval processes.</p>
<h3 style="text-align:left;">Market Implications and Future Outlook</h3>
<p style="text-align:left;">Analysts suggest that if approved, Moderna’s flu vaccine could significantly impact the multi-billion-dollar vaccine market, which includes COVID-19, influenza, and respiratory syncytial virus (RSV). The market landscape is competitive, with Pfizer and Novavax also pursuing similar combination vaccines. Despite lacking specific revenue projections for these individual products, Moderna CEO <strong>Stephane Bancel</strong> expressed optimism, stating, “We’re clearly hoping our products will allow us to secure a fair share of these markets.” Furthermore, the anticipated approval could also lead to better logistical efficiencies within healthcare systems by simplifying vaccination protocols and improving patient compliance.</p>
<h3 style="text-align:left;">Summary of Health Impact and Community Response</h3>
<p style="text-align:left;">The health implications of Moderna’s new vaccine are significant, particularly given recent data from the Centers for Disease Control and Prevention (CDC) that indicate a 15-year high in seasonal flu-related hospitalizations. Reports suggest that over 600,000 Americans required hospitalization due to flu-related conditions last year. In light of this, <strong>Stephen Hoge</strong>, head of research and development at Moderna, has emphasized the critical importance of introducing more effective vaccines to combat influenza. The consistent efficacy results of the mRNA-1010 vaccine across various demographics affirm its potential to diminish the burden of influenza, particularly among vulnerable populations.</p>
<table style="width:100%; text-align:left;">
<thead>
<tr>
<th style="text-align:left;"><strong>No.</strong></th>
<th style="text-align:left;"><strong>Key Points</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">1</td>
<td style="text-align:left;">Moderna&#8217;s mRNA-based flu vaccine demonstrated a stronger immune response than current vaccines in trials.</td>
</tr>
<tr>
<td style="text-align:left;">2</td>
<td style="text-align:left;">A phase three trial showed the vaccine was 26.6% more effective than the standard flu vaccine.</td>
</tr>
<tr>
<td style="text-align:left;">3</td>
<td style="text-align:left;">Regulatory discussions with the FDA are ongoing to ensure compliance and expedite approval.</td>
</tr>
<tr>
<td style="text-align:left;">4</td>
<td style="text-align:left;">The vaccine could play a significant role in reducing healthcare costs and improving patient adherence to vaccination schedules.</td>
</tr>
<tr>
<td style="text-align:left;">5</td>
<td style="text-align:left;">Moderna aims to contribute significantly to the flu vaccine market, which is currently experiencing high demand.</td>
</tr>
</tbody>
</table>
<h2 style="text-align:left;">Summary</h2>
<p style="text-align:left;">Moderna&#8217;s advancements in mRNA-based vaccine technology highlight an important shift in the approach to influenza vaccination. The promising results from recent trials reinforce the urgent call for more effective flu vaccines, especially given the challenges posed by the recent flu season. As the company moves forward with regulatory applications, its commitment to improving public health through innovative solutions positions it as a potential leader in this critical healthcare segment.</p>
<h2 style="text-align:left;">Frequently Asked Questions</h2>
<p><strong>Question: What is the mRNA-1010 vaccine?</strong></p>
<p style="text-align:left;">The mRNA-1010 vaccine is Moderna’s experimental influenza vaccine designed to provide a stronger immune response compared to existing flu shots, utilizing messenger RNA technology.</p>
<p><strong>Question: Why did Moderna withdraw its application for the combination vaccine?</strong></p>
<p style="text-align:left;">Moderna withdrew its application to ensure the submission included robust efficacy data from its phase three trial of its standalone flu vaccine, following consultations with the FDA.</p>
<p><strong>Question: What potential benefits does the dual flu and COVID-19 vaccine offer?</strong></p>
<p style="text-align:left;">The combination vaccine is expected to simplify vaccination processes, reduce healthcare workloads, lower costs, and improve patient uptake, thereby enhancing public health outcomes.</p>
</div>
<p>©2025 News Journos. All rights reserved.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://newsjournos.com/modernas-flu-vaccine-trials-show-promise-for-combined-shot-development/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>How Wendy&#8217;s combined their classic Frosty with a beloved Girl Scout cookie</title>
		<link>https://newsjournos.com/how-wendys-combined-their-classic-frosty-with-a-beloved-girl-scout-cookie/</link>
					<comments>https://newsjournos.com/how-wendys-combined-their-classic-frosty-with-a-beloved-girl-scout-cookie/?noamp=mobile#respond</comments>
		
		<dc:creator><![CDATA[News Editor]]></dc:creator>
		<pubDate>Wed, 19 Feb 2025 13:40:51 +0000</pubDate>
				<category><![CDATA[Entertainment]]></category>
		<category><![CDATA[Award Shows]]></category>
		<category><![CDATA[Behind the Scenes]]></category>
		<category><![CDATA[beloved]]></category>
		<category><![CDATA[Box Office]]></category>
		<category><![CDATA[Celebrity Interviews]]></category>
		<category><![CDATA[Celebrity News]]></category>
		<category><![CDATA[classic]]></category>
		<category><![CDATA[combined]]></category>
		<category><![CDATA[cookie]]></category>
		<category><![CDATA[Documentaries]]></category>
		<category><![CDATA[Entertainment News]]></category>
		<category><![CDATA[Fashion Trends]]></category>
		<category><![CDATA[Film Reviews]]></category>
		<category><![CDATA[Frosty]]></category>
		<category><![CDATA[Girl]]></category>
		<category><![CDATA[Movies]]></category>
		<category><![CDATA[Music]]></category>
		<category><![CDATA[Podcasts]]></category>
		<category><![CDATA[Pop Culture]]></category>
		<category><![CDATA[Reality TV]]></category>
		<category><![CDATA[Red Carpet]]></category>
		<category><![CDATA[Scout]]></category>
		<category><![CDATA[Streaming Services]]></category>
		<category><![CDATA[Television]]></category>
		<category><![CDATA[Theatre]]></category>
		<category><![CDATA[TV Shows]]></category>
		<category><![CDATA[Web Series]]></category>
		<category><![CDATA[Wendys]]></category>
		<guid isPermaLink="false">https://newsjournos.com/how-wendys-combined-their-classic-frosty-with-a-beloved-girl-scout-cookie/</guid>

					<description><![CDATA[<p>This article is published by News Journos</p>
<p>In an exciting announcement for dessert enthusiasts, Wendy&#8217;s is set to introduce a new flavor of its iconic Frosty, inspired by the popular Girl Scout cookie, Thin Mints. Starting February 21, customers will be able to enjoy a delicious blend of the traditional Frosty’s creamy texture with the mint and chocolate flavors reminiscent of Thin [...]</p>
<p>©2025 News Journos. All rights reserved.</p>
]]></description>
										<content:encoded><![CDATA[<p>This article is published by News Journos</p>
<div id="article-0">
<p style="text-align:left;">In an exciting announcement for dessert enthusiasts, Wendy&#8217;s is set to introduce a new flavor of its iconic Frosty, inspired by the popular Girl Scout cookie, Thin Mints. Starting February 21, customers will be able to enjoy a delicious blend of the traditional Frosty’s creamy texture with the mint and chocolate flavors reminiscent of Thin Mints. This development is part of Wendy&#8217;s ongoing efforts to refresh its menu while celebrating nostalgic flavors that resonate with consumers.</p>
<table style="width:100%; text-align:left; border-collapse:collapse;">
<thead>
<tr>
<th style="text-align:left; padding:5px;">
        <strong>Article Subheadings</strong>
      </th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left; padding:5px;">
        <strong>1)</strong> The Evolution of Wendy&#8217;s Frosty
      </td>
</tr>
<tr>
<td style="text-align:left; padding:5px;">
        <strong>2)</strong> Announcement of the Thin Mint Frosty
      </td>
</tr>
<tr>
<td style="text-align:left; padding:5px;">
        <strong>3)</strong> The Development Process of the New Flavor
      </td>
</tr>
<tr>
<td style="text-align:left; padding:5px;">
        <strong>4)</strong> Customer Reactions and Anticipations
      </td>
</tr>
<tr>
<td style="text-align:left; padding:5px;">
        <strong>5)</strong> The Future of Wendy&#8217;s Frosty Lineup
      </td>
</tr>
</tbody>
</table>
<h3 style="text-align:left;">The Evolution of Wendy&#8217;s Frosty</h3>
<p style="text-align:left;">Wendy&#8217;s Frosty has become more than just a dessert; it is a testament to enduring taste and nostalgia in the fast-food industry. When <strong>Dave Thomas</strong>, the founder of Wendy&#8217;s, introduced the Frosty in the late 1960s, he crafted a frozen treat designed to complement the freshly made burgers and fries of the restaurant. Originally available only in chocolate, the Frosty quickly gained popularity and became a staple in Wendy&#8217;s offerings. Reports indicate that over 500 Frostys are served every minute across the U.S., demonstrating its widespread appeal.</p>
<p style="text-align:left;">The Frosty exists in a unique space between soft serve and hard-packed ice cream, offering a texture that has captured the attention of consumers for decades. In 2006, the addition of vanilla expanded the flavor options, although it wasn&#8217;t until 2022 that Wendy&#8217;s tested the waters with limited-time flavors. Across its journey, the Frosty has been a culinary icon, symbolizing not just Wendy&#8217;s brand but also a favorite childhood dessert for many.</p>
<h3 style="text-align:left;">Announcement of the Thin Mint Frosty</h3>
<p style="text-align:left;">As part of its innovative approach, Wendy&#8217;s announced that on February 21, a new flavor will be added to the Frosty lineup: the Thin Mint Frosty. This flavor combines the traditional Frosty texture with the classic taste of a Thin Mint cookie. The excitement around this announcement resonates deeply with fans of both Wendy&#8217;s and Girl Scout cookies. The collaboration hints at a culinary trend of merging beloved snacks and desserts to create unique flavor profiles that appeal to a broad audience.</p>
<p style="text-align:left;">The timing is strategic for Wendy&#8217;s, aligning the introduction of this flavor with Girl Scout cookie season, allowing consumers to indulge in two favorites at once. The anticipation and buzz surrounding this product launch are expected to drive foot traffic into Wendy&#8217;s locations as fans clamor to taste this innovative creation.</p>
<h3 style="text-align:left;">The Development Process of the New Flavor</h3>
<p style="text-align:left;">Creating the Thin Mint Frosty wasn&#8217;t as straightforward as one might imagine. The challenge lay in finding a way to incorporate the flavor of Thin Mints into the already popular dessert without compromising its signature texture. According to <strong>John Li</strong>, Wendy&#8217;s Vice President of Research and Development, the team experimented with various formulations before landing on a successful concept. Instead of using cookie chunks, which could disrupt the Frosty&#8217;s creamy texture, they developed a fudge-like cookie butter.</p>
<p style="text-align:left;">The cookie butter allows for a smooth incorporation of the Thin Mint flavor into the Frosty, ensuring that every sip or bite provides a consistent taste experience. Initially, the team considered launching the flavor as a standalone option. However, they quickly discovered that the swirled flavor worked beautifully in both chocolate and vanilla Frostys, thus enhancing the menu versatility. The thoughtful approach to product development demonstrates Wendy&#8217;s commitment to maintaining high standards of quality while pushing the boundaries of traditional fast-food offerings.</p>
<h3 style="text-align:left;">Customer Reactions and Anticipations</h3>
<p style="text-align:left;">The announcement of the Thin Mint Frosty has sparked a wave of excitement among consumers who are eager to try the innovative flavor. Social media platforms have seen a flurry of posts from fans discussing their enthusiasm for the new flavor and sharing nostalgic memories related to both Wendy’s Frosty and Girl Scout cookies. The blending of these two culinary icons taps into emotions and memories, making it more than just a food item; it is a celebration of shared experiences and desires.</p>
<p style="text-align:left;">Wendy&#8217;s loyal customers have reacted positively, indicating their intention to try the new flavor upon its release. The marketing team has successfully created a sense of urgency and anticipation around this launch, which is expected to translate into strong sales figures. Not only are they excited about the taste, but many fans are also curious about potential future collaborations that blend other popular snack flavors with beloved menu items.</p>
<h3 style="text-align:left;">The Future of Wendy&#8217;s Frosty Lineup</h3>
<p style="text-align:left;">Looking ahead, Wendy&#8217;s continues to prioritize innovation in its Frosty lineup. The success of the Thin Mint flavor may influence the company to explore other collaborations with popular brands or snacks. There is a growing trend within the fast-food industry to introduce limited-time offerings that pique customer interest and encourage repeat visits. Maintaining consumer curiosity and desire through seasonal flavors can create sustained engagement.</p>
<p style="text-align:left;">As Wendy’s has demonstrated, their willingness to reinvent traditional menu items signals a robust future for the Frosty. This adaptability may solidify the Frosty&#8217;s status as an ongoing favorite, attracting new customers while retaining their loyal fanbase. Wendy&#8217;s has a unique opportunity to secure its place in fast-food history by continuing to innovate and celebrate nostalgic flavors that resonate with a diverse audience.</p>
<table style="width:100%; text-align:left;">
<thead>
<tr>
<th style="text-align:left;"><strong>No.</strong></th>
<th style="text-align:left;"><strong>Key Points</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">1</td>
<td style="text-align:left;">Wendy&#8217;s has announced a new Thin Mint flavor for its Frosty, launching on February 21.</td>
</tr>
<tr>
<td style="text-align:left;">2</td>
<td style="text-align:left;">The Frosty, a long-standing product, has evolved from its original chocolate and vanilla options to include limited-time offerings.</td>
</tr>
<tr>
<td style="text-align:left;">3</td>
<td style="text-align:left;">The development of the Thin Mint flavor included creating a fudge-like cookie butter to blend well with the Frosty&#8217;s texture.</td>
</tr>
<tr>
<td style="text-align:left;">4</td>
<td style="text-align:left;">Customer reactions have been enthusiastic, showcasing nostalgia and excitement for the new flavor.</td>
</tr>
<tr>
<td style="text-align:left;">5</td>
<td style="text-align:left;">Wendy&#8217;s is expected to continue exploring innovative flavors and collaborations in the future.</td>
</tr>
</tbody>
</table>
<h2 style="text-align:left;">Summary</h2>
<p style="text-align:left;">The upcoming launch of Wendy&#8217;s Thin Mint Frosty illustrates the fast-food chain&#8217;s dedication to integrating popular cultural elements into its menu while maintaining quality. This innovative offering is expected to resonate with consumers, tapping into nostalgia while driving excitement and sales. As Wendy’s continues to evolve its Frosty lineup, the introduction of new flavors might enhance its reputation as a leader in fast-food innovation.</p>
<h2 style="text-align:left;">Frequently Asked Questions</h2>
<p><strong>Question: When will the Thin Mint Frosty be available? </strong></p>
<p style="text-align:left;">The Thin Mint Frosty will be available starting on February 21.</p>
<p><strong>Question: What is unique about the Thin Mint Frosty compared to other flavors? </strong></p>
<p style="text-align:left;">The Thin Mint Frosty combines the classic Frosty texture with a fudge-like cookie butter that incorporates the flavor of Thin Mint cookies.</p>
<p><strong>Question: How has Wendy&#8217;s Frosty evolved over the years? </strong></p>
<p style="text-align:left;">Initially offered in chocolate, the Frosty has expanded to include vanilla and limited-time flavors, aiming to keep the product fresh and appealing to consumers.</p>
</div>
<p>©2025 News Journos. All rights reserved.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://newsjournos.com/how-wendys-combined-their-classic-frosty-with-a-beloved-girl-scout-cookie/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
